Allergan Hits Aurobindo With IP Suit Over Pinkeye Drug
Allergan Inc. and two Japanese pharmaceutical companies filed a lawsuit Friday against Aurobindo Pharma Ltd. in Delaware federal court, alleging Aurobindo's bid to market a generic version of pinkeye medication Zymaxid...To view the full article, register now.
Already a subscriber? Click here to view full article